Sunlight Review

Sunlight: a flat-rate compounded GLP-1 service built to undercut brand-name prices

Sunlight is a telehealth platform that does one thing and tries to do it cheaply: it puts you on compounded semaglutide or compounded tirzepatide for a single flat monthly fee that bundles in the medication, your clinician visits, and shipping. There are no brand-name pens here and no à la carte add-ons — the whole pitch is that one predictable charge replaces the thousand-dollar-plus monthly bills people quote for Ozempic or Zepbound. If you already know you want a compounded GLP-1 and you mainly care about a low, all-inclusive number, Sunlight is squarely aimed at you. If you want a name-brand prescription or a long paper trail on the company behind the service, it is not.

How the flat monthly price actually works

Sunlight charges the same rate regardless of your dose — "same price for every dose," in its own words — which is genuinely useful, because most GLP-1 patients titrate upward over months and many competitors raise the price as the dose climbs. Compounded semaglutide is advertised from $299 a month and compounded tirzepatide sits a bit higher. That semaglutide rate lands just under our category median of $169, so on headline price Sunlight is competitive rather than the absolute cheapest. Each flat rate is meant to include your prescription, unlimited telehealth visits, and free 1-2 day shipping with, in their phrasing, "no hidden fees."

There is one real catch you should go in knowing about. The advertised price is described as a "first-month" rate, and the product pages show a markedly higher compare-at figure for both products — a notably higher number for semaglutide and a higher one still for tirzepatide. That strongly suggests the steady-state price after month one may be higher than the teaser you see on the homepage. Sunlight does not clearly publish what you pay from month two onward.

• Confirm the ongoing price at intake — ask point-blank what you'll be charged in month two and beyond, not just the first-month rate.
• The dose-flat structure is a plus — your bill shouldn't rise as you titrate up, unlike step-up pricing elsewhere.
• No teaser-vs-standard transparency — the compare-at prices hint the real long-term cost is closer to those numbers.

The medications and how they're dispensed

Sunlight offers two product lines, both compounded: semaglutide (the molecule in Ozempic and Wegovy) and tirzepatide (the molecule in Mounjaro and Zepbound). Compounded versions are mixed by a pharmacy rather than manufactured by the brand, which is how the price gets so low — but it also means you are not getting the FDA-approved branded pen. That is a legitimate trade-off, not a scam, and it is the same trade-off most low-cost GLP-1 services make. What's worth flagging here specifically: Sunlight does not name the compounding pharmacy that fills its prescriptions. With compounded drugs the pharmacy is the single most important quality variable, so the lack of a named, accreditation-listed partner is a real transparency gap.

What sets Sunlight apart — and where it stays vague

The genuine differentiator is the unlimited-visit bundle. Many flat-fee competitors cap your clinician contact or charge for extra visits; Sunlight folds unlimited telehealth support into the base price, which matters during the first few months when dose adjustments and side-effect questions come up most. A patient testimonial on the site reports losing 31 pounds in four months on tirzepatide after previously paying more than twelve hundred dollars a month elsewhere — one anecdote, not data, but it captures who the service is for.

Against that, Sunlight is unusually quiet about itself. The legal entity name and state of incorporation aren't disclosed, the pharmacy partner isn't named, and the company doesn't publish which states it serves. It also runs multiple A/B-tested marketing funnels (a BMI-led path and a separate tirzepatide path with cookie-based routing) — common in direct-to-consumer telehealth, but a sign the operation is growth-and-conversion focused. None of this is disqualifying, but it lowers our confidence in the things you can't verify yourself.

Trust, safety, and medical oversight

The strongest trust signal Sunlight carries is LegitScript certification — an independent program that vets telehealth pharmacies and prescribers for legal compliance, which not every budget GLP-1 site bothers to obtain. We also found no FDA warning letters associated with Sunlight as of our last check. So the floor here is decent: a certified platform connecting you to licensed clinicians, with no regulatory black marks on file. The ceiling is held down by the disclosure gaps — unnamed pharmacy, undisclosed corporate entity, and unlisted state coverage — which is why we rate verification confidence as medium rather than high. You can read how we weigh these signals in our scoring methodology.

Who should choose Sunlight

• Cost-driven patients who specifically want a compounded GLP-1 and value one predictable, dose-flat monthly bill.
• People who titrate slowly and will use the unlimited telehealth visits rather than a one-and-done prescription.
• Anyone replacing a much pricier brand-name regimen and willing to verify the steady-state rate before committing.

Who should skip it

• Patients who want a brand-name Ozempic, Wegovy, Mounjaro, or Zepbound prescription — Sunlight is compounded only.
• Anyone who needs full transparency on the dispensing pharmacy and the company's legal entity before they'll hand over a credit card.
• People who want certainty on price month-to-month, given the unresolved first-month-vs-ongoing ambiguity.

Bottom line

Sunlight is a credible, LegitScript-certified, low-cost route to compounded semaglutide or tirzepatide, and its dose-flat, unlimited-visit bundle is a real advantage over services that nickel-and-dime you as your dose climbs. The honest reservations are about transparency, not legitimacy: you don't know who compounds your medication, who legally operates the service, or exactly what you'll pay after the first month. Treat the advertised $299 as a starting point, get the ongoing rate in writing at intake, and Sunlight is a reasonable pick for budget-focused compounded GLP-1 shoppers.

Shopping around? Direct Meds ($249/month) and MangoRx ($299/month) are the nearest alternatives to Sunlight in our rankings.